NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Balance Sheet
NASDAQ:NMTC - Nasdaq - US64130M2098 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.32M | 1.46M | 5.32M | 8.16M | 6.90M | |||
| Marketable Securities | N/A | N/A | 0.00 | 2.98M | N/A | |||
| Receivables | 318.80K | 176.60K | 0.00 | 30.00K | 50.00K | |||
| Inventories | 1.83M | 2.64M | 1.73M | 700.00K | 100.00K | |||
| Other Current Assets | 280.40K | 359.10K | 263.80K | 300.00K | 240.00K | |||
| Total Current Assets | 3.75M | 4.63M | 7.31M | 12.18M | 7.29M | |||
| Non-Current Assets | ||||||||
| PPE Net | 646.50K | 671.80K | 694.80K | 530.00K | 510.00K | |||
| Intangibles | 56.10K | 67.30K | 89.60K | 110.00K | 130.00K | |||
| Total Non-Current Assets | 702.60K | 739.00K | 784.40K | 640.00K | 650.00K | |||
| TOTAL ASSETS | 4.46M | 5.37M | 8.10M | 12.82M | 7.94M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 852.60K | 1.18M | 1.11M | 720.00K | 640.00K | |||
| Accounts Payable | 910.80K | 1.03M | 685.10K | 930.00K | 530.00K | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 1.46M | 10.00K | |||
| Total Current Liabilities | 1.76M | 2.21M | 1.79M | 3.10M | 1.18M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.36M | 2.14M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 207.00K | 194.40K | 55.30K | 120.00K | 200.00K | |||
| Total Non-Current Liabilities | 1.57M | 2.33M | 55.30K | 120.00K | 200.00K | |||
| TOTAL LIABILITIES | 3.33M | 4.55M | 1.85M | 3.22M | 1.38M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -75.49M | -75.00M | -62.69M | -50.83M | -40.83M | |||
| Additional Paid In Capital | 76.58M | 75.80M | 68.91M | 60.41M | 47.35M | |||
| Common Shares | 31.40K | 30.80K | 23.90K | 20.00K | 40.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 31.39M | 30.82M | 23.93M | 16.22M | 12.01M | |||
| Tangible Book Value per Share | 0.03 | 0.02 | 0.26 | 0.59 | 0.53 | |||
| Total Shareholders' Equity | 1.13M | 822.00K | 6.25M | 9.60M | 6.55M | |||
| TOTAL LIABILITIES AND EQUITY | 4.46M | 5.37M | 8.10M | 12.82M | 7.94M | |||
| Statistics | ||||||||
| Debt/Equity | 1.21 | 2.60 | N/A | N/A | N/A | |||
| Current Ratio | 2.13 | 2.09 | 4.08 | 3.93 | 6.18 | |||
| Return On Assets (ROA) | -148.22% | -229.39% | -146.46% | -78.00% | -125.31% | |||
| Return On Equity (ROE) | -586.72% | -1498.55% | -189.77% | -104.17% | -151.91% | |||
All data in USD , ROIC based on taxRate of 0.21